Is NTGR or CAMP more profitable?

NETGEAR has a net margin of -3.58% compared to CAMP4 Therapeutics' net margin of -2,193.72%. NETGEAR's return on equity of -2.71% beat CAMP4 Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets NETGEAR -3.58% -2.71% -1.66% CAMP4 Therapeutics -2,193.72% -194.74% -95.64%

Does the media prefer NTGR or CAMP?

In the previous week, CAMP4 Therapeutics had 1 more articles in the media than NETGEAR. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 5 mentions for NETGEAR. NETGEAR's average media sentiment score of 0.53 beat CAMP4 Therapeutics' score of -0.13 indicating that NETGEAR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NETGEAR 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CAMP4 Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAMP or RBBN?

In the previous week, CAMP4 Therapeutics had 5 more articles in the media than Ribbon Communications. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 1 mentions for Ribbon Communications. Ribbon Communications' average media sentiment score of 0.00 beat CAMP4 Therapeutics' score of -0.13 indicating that Ribbon Communications is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CAMP4 Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ribbon Communications 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CAMP or KVHI?

CAMP4 Therapeutics presently has a consensus price target of $8.36, indicating a potential upside of 177.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CAMP4 Therapeutics 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.56 KVH Industries 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor CAMP or KVHI?

In the previous week, CAMP4 Therapeutics had 5 more articles in the media than KVH Industries. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 1 mentions for KVH Industries. KVH Industries' average media sentiment score of 0.86 beat CAMP4 Therapeutics' score of -0.13 indicating that KVH Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CAMP4 Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral KVH Industries 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CMTL or CAMP?

In the previous week, CAMP4 Therapeutics had 3 more articles in the media than Comtech Telecommunications. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 3 mentions for Comtech Telecommunications. Comtech Telecommunications' average media sentiment score of 0.53 beat CAMP4 Therapeutics' score of -0.13 indicating that Comtech Telecommunications is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Comtech Telecommunications 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CAMP4 Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CAMP4 Therapeutics (CAMP) Competitors

$3.01 -0.10 (-3.22%)

Closing price 04:00 PM Eastern

Extended Trading

$3.08 +0.07 (+2.16%)

As of 07:34 PM Eastern

Compare

CAMP vs. NTGR, RBBN, AVNW, KVHI, and CMTL

Should you buy CAMP4 Therapeutics stock or one of its competitors? MarketBeat compares CAMP4 Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CAMP4 Therapeutics include NETGEAR (NTGR), Ribbon Communications (RBBN), Aviat Networks (AVNW), KVH Industries (KVHI), and Comtech Telecommunications (CMTL). These companies are all part of the "communications equipment" industry.

How does CAMP4 Therapeutics compare to NETGEAR?

NETGEAR (NASDAQ:NTGR) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

NETGEAR has higher revenue and earnings than CAMP4 Therapeutics. NETGEAR is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NETGEAR	$699.62M	0.96	-$17.92M	-$0.88	N/A
CAMP4 Therapeutics	$3.50M	44.66	-$80.40M	-$2.36	N/A

83.0% of NETGEAR shares are owned by institutional investors. 3.1% of NETGEAR shares are owned by company insiders. Comparatively, 21.7% of CAMP4 Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

NETGEAR has a net margin of -3.58% compared to CAMP4 Therapeutics' net margin of -2,193.72%. NETGEAR's return on equity of -2.71% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NETGEAR	-3.58%	-2.71%	-1.66%
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%

NETGEAR presently has a consensus target price of $36.00, suggesting a potential upside of 43.71%. CAMP4 Therapeutics has a consensus target price of $8.36, suggesting a potential upside of 177.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than NETGEAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NETGEAR	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
CAMP4 Therapeutics	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56

NETGEAR has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

In the previous week, CAMP4 Therapeutics had 1 more articles in the media than NETGEAR. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 5 mentions for NETGEAR. NETGEAR's average media sentiment score of 0.53 beat CAMP4 Therapeutics' score of -0.13 indicating that NETGEAR is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NETGEAR	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CAMP4 Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NETGEAR beats CAMP4 Therapeutics on 9 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Ribbon Communications?

CAMP4 Therapeutics (NASDAQ:CAMP) and Ribbon Communications (NASDAQ:RBBN) are both small-cap communications equipment companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Ribbon Communications has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Ribbon Communications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CAMP4 Therapeutics	$3.50M	44.66	-$80.40M	-$2.36	N/A
Ribbon Communications	$844.56M	0.42	$39.64M	$0.17	11.88

70.9% of Ribbon Communications shares are held by institutional investors. 21.7% of CAMP4 Therapeutics shares are held by company insiders. Comparatively, 4.0% of Ribbon Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, CAMP4 Therapeutics had 5 more articles in the media than Ribbon Communications. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 1 mentions for Ribbon Communications. Ribbon Communications' average media sentiment score of 0.00 beat CAMP4 Therapeutics' score of -0.13 indicating that Ribbon Communications is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CAMP4 Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ribbon Communications	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CAMP4 Therapeutics has a beta of 0.1, suggesting that its share price is 90% less volatile than the broader market. Comparatively, Ribbon Communications has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market.

Ribbon Communications has a net margin of 3.80% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Ribbon Communications' return on equity of 24.14% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%
Ribbon Communications	3.80%	24.14%	8.35%

CAMP4 Therapeutics presently has a consensus price target of $8.36, indicating a potential upside of 177.65%. Ribbon Communications has a consensus price target of $3.58, indicating a potential upside of 77.23%. Given CAMP4 Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Ribbon Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CAMP4 Therapeutics	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56
Ribbon Communications	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Ribbon Communications beats CAMP4 Therapeutics on 10 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Aviat Networks?

CAMP4 Therapeutics (NASDAQ:CAMP) and Aviat Networks (NASDAQ:AVNW) are both small-cap communications equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

78.6% of Aviat Networks shares are owned by institutional investors. 21.7% of CAMP4 Therapeutics shares are owned by insiders. Comparatively, 5.3% of Aviat Networks shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aviat Networks has higher revenue and earnings than CAMP4 Therapeutics. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Aviat Networks, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CAMP4 Therapeutics	$3.50M	44.66	-$80.40M	-$2.36	N/A
Aviat Networks	$434.61M	0.61	$1.34M	$0.69	29.49

In the previous week, CAMP4 Therapeutics had 6 more articles in the media than Aviat Networks. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 0 mentions for Aviat Networks. Aviat Networks' average media sentiment score of 0.56 beat CAMP4 Therapeutics' score of -0.13 indicating that Aviat Networks is being referred to more favorably in the news media.

Company	Overall Sentiment
CAMP4 Therapeutics	Neutral
Aviat Networks	Positive

Aviat Networks has a net margin of 2.08% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Aviat Networks' return on equity of 6.89% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%
Aviat Networks	2.08%	6.89%	2.89%

CAMP4 Therapeutics currently has a consensus price target of $8.36, suggesting a potential upside of 177.65%. Aviat Networks has a consensus price target of $33.14, suggesting a potential upside of 62.86%. Given CAMP4 Therapeutics' higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Aviat Networks.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CAMP4 Therapeutics	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56
Aviat Networks	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

CAMP4 Therapeutics has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market. Comparatively, Aviat Networks has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

Summary

Aviat Networks beats CAMP4 Therapeutics on 12 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to KVH Industries?

CAMP4 Therapeutics (NASDAQ:CAMP) and KVH Industries (NASDAQ:KVHI) are both small-cap communications equipment companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

CAMP4 Therapeutics has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market. Comparatively, KVH Industries has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

73.7% of KVH Industries shares are held by institutional investors. 21.7% of CAMP4 Therapeutics shares are held by insiders. Comparatively, 21.4% of KVH Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

KVH Industries has a net margin of -4.31% compared to CAMP4 Therapeutics' net margin of -2,193.72%. KVH Industries' return on equity of -0.80% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%
KVH Industries	-4.31%	-0.80%	-0.70%

CAMP4 Therapeutics presently has a consensus price target of $8.36, indicating a potential upside of 177.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CAMP4 Therapeutics	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56
KVH Industries	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

KVH Industries has higher revenue and earnings than CAMP4 Therapeutics. KVH Industries is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CAMP4 Therapeutics	$3.50M	44.66	-$80.40M	-$2.36	N/A
KVH Industries	$111.01M	1.58	-$7.38M	-$0.26	N/A

In the previous week, CAMP4 Therapeutics had 5 more articles in the media than KVH Industries. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 1 mentions for KVH Industries. KVH Industries' average media sentiment score of 0.86 beat CAMP4 Therapeutics' score of -0.13 indicating that KVH Industries is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CAMP4 Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KVH Industries	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

KVH Industries beats CAMP4 Therapeutics on 9 of the 16 factors compared between the two stocks.

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Comtech Telecommunications (NASDAQ:CMTL) and CAMP4 Therapeutics (NASDAQ:CAMP) are both small-cap communications equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

In the previous week, CAMP4 Therapeutics had 3 more articles in the media than Comtech Telecommunications. MarketBeat recorded 6 mentions for CAMP4 Therapeutics and 3 mentions for Comtech Telecommunications. Comtech Telecommunications' average media sentiment score of 0.53 beat CAMP4 Therapeutics' score of -0.13 indicating that Comtech Telecommunications is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Comtech Telecommunications	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CAMP4 Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CAMP4 Therapeutics has lower revenue, but higher earnings than Comtech Telecommunications. CAMP4 Therapeutics is trading at a lower price-to-earnings ratio than Comtech Telecommunications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Comtech Telecommunications	$499.53M	0.11	-$155.30M	-$2.21	N/A
CAMP4 Therapeutics	$3.50M	44.66	-$80.40M	-$2.36	N/A

Comtech Telecommunications presently has a consensus target price of $2.50, indicating a potential upside of 42.05%. CAMP4 Therapeutics has a consensus target price of $8.36, indicating a potential upside of 177.65%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe CAMP4 Therapeutics is more favorable than Comtech Telecommunications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Comtech Telecommunications	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CAMP4 Therapeutics	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56

Comtech Telecommunications has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, CAMP4 Therapeutics has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

Comtech Telecommunications has a net margin of -5.52% compared to CAMP4 Therapeutics' net margin of -2,193.72%. Comtech Telecommunications' return on equity of 9.77% beat CAMP4 Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Comtech Telecommunications	-5.52%	9.77%	1.05%
CAMP4 Therapeutics	-2,193.72%	-194.74%	-95.64%

Summary

Comtech Telecommunications beats CAMP4 Therapeutics on 8 of the 14 factors compared between the two stocks.

Get CAMP4 Therapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CAMP vs. The Competition

Export

Metric	CAMP4 Therapeutics	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$161.49M	$3.64B	$6.82B	$12.60B
Dividend Yield	N/A	2.19%	2.68%	9.52%
P/E Ratio	-1.28	11.33	22.09	21.54
Price / Sales	44.66	304.04	522.13	92.26
Price / Cash	N/A	156.74	50.43	59.93
Price / Book	2.95	8.01	10.18	6.10
Net Income	-$80.40M	$23.81M	$3.60B	$331.84M
7 Day Performance	-22.82%	-1.69%	-1.95%	-1.77%
1 Month Performance	-30.96%	-1.69%	-0.77%	-3.03%
1 Year Performance	79.70%	34.50%	19.01%	14.20%

CAMP4 Therapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CAMP CAMP4 Therapeutics	2.8791 of 5 stars	$3.01 -3.2%	$8.36 +177.6%	+90.8%	$161.49M	$3.50M	N/A	644	News Coverage
NTGR NETGEAR	2.1324 of 5 stars	$24.16 -0.4%	$36.00 +49.0%	-5.4%	$648.00M	$696.38M	N/A	690	News Coverage High Trading Volume
RBBN Ribbon Communications	4.1396 of 5 stars	$2.24 -1.4%	$3.58 +60.0%	-46.4%	$399.84M	$825.88M	13.24	3,080	Upcoming Earnings
AVNW Aviat Networks	4.4736 of 5 stars	$20.81 +0.2%	$33.14 +59.3%	-13.5%	$267.84M	$434.14M	30.00	710	News Coverage
KVHI KVH Industries	0.7399 of 5 stars	$9.27 -0.4%	N/A	+74.1%	$180.67M	$111.01M	N/A	650	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CAMP) was last updated on 7/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CAMP4 Therapeutics (CAMP) Competitors

CAMP vs. NTGR, RBBN, AVNW, KVHI, and CMTL

How does CAMP4 Therapeutics compare to NETGEAR?

Summary

How does CAMP4 Therapeutics compare to Ribbon Communications?

Summary

How does CAMP4 Therapeutics compare to Aviat Networks?

Summary

How does CAMP4 Therapeutics compare to KVH Industries?

Summary

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CAMP vs. The Competition

CAMP4 Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CAMP4 Therapeutics (CAMP) Competitors

CAMP vs. NTGR, RBBN, AVNW, KVHI, and CMTL

How does CAMP4 Therapeutics compare to NETGEAR?

Which has higher earnings & valuation, NTGR or CAMP?

Do institutionals & insiders have more ownership in NTGR or CAMP?

Is NTGR or CAMP more profitable?

Do analysts prefer NTGR or CAMP?

Which has more risk and volatility, NTGR or CAMP?

Does the media prefer NTGR or CAMP?

Summary

How does CAMP4 Therapeutics compare to Ribbon Communications?

Which has stronger valuation & earnings, CAMP or RBBN?

Do insiders & institutionals hold more shares of CAMP or RBBN?

Does the media refer more to CAMP or RBBN?

Which has more volatility and risk, CAMP or RBBN?

Is CAMP or RBBN more profitable?

Do analysts prefer CAMP or RBBN?

Summary

How does CAMP4 Therapeutics compare to Aviat Networks?

Do insiders & institutionals hold more shares of CAMP or AVNW?

Which has better valuation and earnings, CAMP or AVNW?

Does the media favor CAMP or AVNW?

Is CAMP or AVNW more profitable?

Do analysts rate CAMP or AVNW?

Which has more risk and volatility, CAMP or AVNW?

Summary

How does CAMP4 Therapeutics compare to KVH Industries?

Which has more risk & volatility, CAMP or KVHI?

Do insiders and institutionals believe in CAMP or KVHI?

Is CAMP or KVHI more profitable?

Do analysts rate CAMP or KVHI?

Which has preferable valuation and earnings, CAMP or KVHI?

Does the media favor CAMP or KVHI?

Summary

How does CAMP4 Therapeutics compare to Comtech Telecommunications?

Does the media refer more to CMTL or CAMP?

Which has higher valuation and earnings, CMTL or CAMP?

Do analysts rate CMTL or CAMP?

Which has more risk & volatility, CMTL or CAMP?

Is CMTL or CAMP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CAMP vs. The Competition

CAMP4 Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools